Test Price
2,800 AED✅ Home Collection Available
CHST8 Gene Peeling Skin Syndrome Type 3 Genetic Test – 2,800 AED
Executive Summary & Core Metrics
Executive Summary: 99.9% diagnostic sensitivity via ISO-accredited processing. Premium at-home sample collection with temperature-controlled cold-chain logistics. Post-test genetic counseling included. Insurance direct billing verification via WhatsApp at +971 54 548 8731.
Core Metrics: Sensitivity ≥99.9% | Turnaround Time 3–4 Weeks | Price 2,800 AED | DHA License 1143
Test Overview & Methodology
The CHST8 Gene Peeling Skin Syndrome Type 3 NGS Test employs Next-Generation Sequencing to detect pathogenic variants in the CHST8 gene, confirming a clinical diagnosis of acral peeling skin syndrome type 3 and guiding carrier screening for at-risk families in the UAE.
| Feature | Our Test (CHST8 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | ≥99.9% sensitivity for SNVs, indels, and select CNVs | ~98% sensitivity; limited to targeted amplicons |
| Method | Next-Generation Sequencing (whole gene) | Sanger sequencing (exon-by-exon) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Cost (UAE) | 2,800 AED | Not directly comparable; often higher when outsourced |
| DHA License | Facility License 1143 | Varies by provider |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403) advises: “A positive CHST8 result must be clinically correlated with dermatological and family history. Genetic counselling is mandatory before and after testing to discuss inheritance and psychosocial implications. Children should always be assessed by a paediatric dermatologist.”
Medication Advisory
Do not discontinue any prescribed medication without explicit instruction from your treating physician. Topical steroids or emollients do not interfere with the genetic test.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Minors (<18 years) must be accompanied by a legal guardian. Inability to provide a valid blood sample (severe phlebotomy contraindications).
- Red Flag – Postpone Test: Acute febrile illness, active systemic infection, or localised skin infection at the venipuncture site.
- Red Flag – Seek Immediate Care: Severe blistering, skin fragility crises, or signs of secondary infection should be evaluated by a dermatologist before sample collection.
- Consent: Written informed consent for genetic testing is mandatory under Federal Decree-Law No. 4 of 2016 on Medical Liability and the UAE Personal Data Protection Law (Federal Decree-Law No. 45 of 2021).
Patient FAQ & Clinical Guidance
1. What does the CHST8 NGS test detect and how reliable is it?
The test sequences the entire CHST8 gene using Next-Generation Sequencing, identifying disease-causing mutations with a clinical sensitivity exceeding 99.9%.
2. Is fasting or special preparation required before sample collection?
No fasting or special preparation is required before the blood draw. A detailed family history form will be provided during the pre-test genetic counselling session.
3. How will I receive my results and what happens next?
Your report will be securely delivered within 3–4 weeks via encrypted email, accompanied by a telephonic genetic counselling appointment. Positive results include a referral pathway to specialist dermatology and clinical genetics teams in Dubai and Abu Dhabi.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This diagnostic service adheres to the following UAE regulations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
Processing is performed under ISO 9001:2015 certification (Certificate No: INT/EGQ/2509DA/3139). DHA Facility License: 1143. Laboratory address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
For insurance pre-approval or home collection scheduling, contact: +971 54 548 8731 (WhatsApp).
Clinical & Logistical Metadata
| Test Name | CHST8 Gene Peeling Skin Syndrome Type 3 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (Whole Gene) |
| ICD-10-CM Code | Q82.8 |
| LOINC Code | 93957-3 |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians